Lexagene Holdings (Lexagene Holdings) EPS (Basic) : $-0.07 (TTM As of Nov. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings EPS (Basic)?

Lexagene Holdings's basic earnings per share (Basic EPS) for the three months ended in Nov. 2022 was $-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Nov. 2022 was $-0.07.

Lexagene Holdings's EPS (Diluted) for the three months ended in Nov. 2022 was $-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Nov. 2022 was $-0.07.

Lexagene Holdings's EPS without NRI for the three months ended in Nov. 2022 was $-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Nov. 2022 was -0.07.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Lexagene Holdings EPS (Basic) Historical Data

The historical data trend for Lexagene Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings EPS (Basic) Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

EPS (Basic)

Get a 7-Day Free Trial

-0.08

-0.13

-0.10

-0.09

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
EPS (Basic)	Get a 7-Day Free Trial															-0.02	-0.02	-0.02	-0.02	-0.01

Lexagene Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Lexagene Holdings's Basic EPS for the fiscal year that ended in Feb. 2022 is calculated as

Basic EPS (A: Feb. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-10.62	-	0)	/	119.976
	=	-0.09

Lexagene Holdings's Basic EPS for the quarter that ended in Nov. 2022 is calculated as

Basic EPS (Q: Nov. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.678	-	0)	/	139.009
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07

Lexagene Holdings (OTCPK:LXXGQ) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Lexagene Holdings EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.